157 related articles for article (PubMed ID: 1691522)
1. Inhibition of PAF-induced histamine secretion and bronchoconstriction by WEB 2086.
Chand N; Pillar J; Nolan K; Diamantis W; Sofia RD
Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):155-8. PubMed ID: 1691522
[TBL] [Abstract][Full Text] [Related]
2. The action of platelet activating factor and its antagonism by WEB 2086 on human isolated airways.
Johnson PR; Armour CL; Black JL
Eur Respir J; 1990 Jan; 3(1):55-60. PubMed ID: 2311732
[TBL] [Abstract][Full Text] [Related]
3. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
[TBL] [Abstract][Full Text] [Related]
5. Limited interference of specific Paf antagonists with hyper-responsiveness to Paf itself of lungs from actively sensitized guinea-pigs.
Pretolani M; Lefort J; Vargaftig BB
Br J Pharmacol; 1989 Jun; 97(2):433-42. PubMed ID: 2474345
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
7. Interference of WEB 2086 and BN 52021 with Paf-induced effects on guinea-pig trachea.
Brunelleschi S; Renzi D; Ledda F; Giotti A; Fantozzi R; Brink C; Benveniste J
Br J Pharmacol; 1989 Jun; 97(2):469-74. PubMed ID: 2758225
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
[TBL] [Abstract][Full Text] [Related]
9. Effects of apafant on PAF-induced downregulation of beta-adrenoceptors in guinea pigs.
Sugimoto Y; Nakayama Y; Kishida H; Hayakawa T; Fujiwara R; Kamei C
Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):547-52. PubMed ID: 9442478
[TBL] [Abstract][Full Text] [Related]
10. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
Pretolani M; Lefort J; Malanchère E; Vargaftig BB
Eur J Pharmacol; 1987 Aug; 140(3):311-21. PubMed ID: 3653247
[TBL] [Abstract][Full Text] [Related]
11. [Characterization of platelet-activating factor (PAF)-receptors in neutrophilic and eosinophilic granulocytes].
Ukena D; Dent G; Chanez P; Barnes PJ; Sybrecht GW
Pneumologie; 1990 Feb; 44 Suppl 1():531-2. PubMed ID: 2164200
[TBL] [Abstract][Full Text] [Related]
12. The effect of the selective PAF antagonist WEB 2170 on PAF and antigen induced airway hyperresponsiveness and eosinophil infiltration.
Seeds EA; Coyle AJ; Page CP
J Lipid Mediat; 1991; 4(1):111-21. PubMed ID: 1893085
[TBL] [Abstract][Full Text] [Related]
13. Histamine release from rabbit platelets by platelet-activating factor (PAF).
Nakahodo K; Saitoh S; Nakamura M; Kosugi T
Arerugi; 1994 Mar; 43(3):501-10. PubMed ID: 7515227
[TBL] [Abstract][Full Text] [Related]
14. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man.
Evans TW; Dent G; Rogers DF; Aursudkij B; Chung KF; Barnes PJ
Br J Pharmacol; 1988 May; 94(1):164-8. PubMed ID: 3401633
[TBL] [Abstract][Full Text] [Related]
15. Early and late tracheobronchial plasma exudation by platelet-activating factor administered to the airway mucosal surface in guinea pigs: effects of WEB 2086 and enprofylline.
O'Donnell SR; Erjefält I; Persson CG
J Pharmacol Exp Ther; 1990 Jul; 254(1):65-70. PubMed ID: 2366192
[TBL] [Abstract][Full Text] [Related]
16. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
[TBL] [Abstract][Full Text] [Related]
17. WEB 2347: pharmacology of a new very potent and long acting hetrazepinoic PAF-antagonist and its action in repeatedly sensitized guinea-pigs.
Heuer HO
J Lipid Mediat; 1991; 4(1):39-44. PubMed ID: 1893086
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor induces eosinophil peroxidase release from purified human eosinophils.
Kroegel C; Yukawa T; Dent G; Chanez P; Chung KF; Barnes PJ
Immunology; 1988 Jul; 64(3):559-61. PubMed ID: 3410498
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
[TBL] [Abstract][Full Text] [Related]
20. The effect of Paf antagonists on bronchial hyperresponsiveness induced by Paf, propranolol or indomethacin.
Dixon EJ; Wilsoncroft P; Robertson DN; Page CP
Br J Pharmacol; 1989 Jul; 97(3):717-22. PubMed ID: 2758238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
